Prenetics

$0 to $120M run rate in 11 months. $10M in revenue by month 12. $300M ARR target by the end of 2026. Those are the numbers behind @im8health, one of the fastest-growing supplement brands in the world right now. Premium positioning. Category-level trust. And a customer journey that converts because it educates, not over-promises. This is what it looks like when you build a brand to scale from day one, not chase short-term acquisition. Full episode with @DannyYeung_ is live now: youtu.be/ChW9gd4nSNU

What do you think it’s like working with David Beckham to build a company? I’d be lying if I didn’t say I wasn’t at least a little curious. No major celebs over here at my brands. But on this episode of Operators Titans, we got to talk with @DannyYeung_ . He’s the co-founder and CEO of IM8. Yes, that’s David Beckham’s supplement company. Their growth rate on ARR has been meteoric. The stuff of legend. This isn’t an episode you’re going to want to miss. Link in the next post 👇👇👇

Our hearts are with Tai Po. We’re donating HK$500,000 to the “Support Fund for Wang Fuk Court in Tai Po”. We stand in solidarity with our community, extend our deepest condolences to all who are grieving, and invite those who can to support relief efforts.

I increased my personal ownership in Prenetics with 40,118 shares (US$502K) purchased in the open market. Our full C-suite invested US$1.45M together. We’re aligned with shareholders and confident in IM8’s and our Bitcoin strategy’s long-term trajectory.

Prenetics (NASDAQ:PRE) Weekly #BitcoinTreasury Update

Prenetics $48M Post-IPO Round⚡️ 📑 About: @Prenetics is a health-sciences company. 🤝 Investors: Kraken, DL Holdings, Exodus, XtalPi, and others. 👉 cryptorank.io/ico/prenetics

Prenetics (NASDAQ:PRE) Weekly #BitcoinTreasury Update

@jasonyimco 🚀

0-100m ARR in 11 months, fastest growing supplements brand outpacing AI companies like Cursor and Perplexity Ever heard of Prenetics? They were known for DNA tests like CircleDNA you spit in a tube, and they tell you your health risks and family history. They’ve officially made the decision to fully pivot to IM8, the health supplement co founded with David Beckham Prenetics reports very favorable metrics, suggesting that the money they are spending on marketing is highly efficient -Customer Acquisition Cost (CAC): As of the first half of 2025, the CAC for IM8 was reported to be $104.00 -Lifetime Value (LTV) to CAC Ratio: The projected 12-Month LTV was approximately $500, resulting in an implied LTV/CAC ratio of 4.8x. Anything above 3 is excellent -Payback Period: IM8 has a 3.9 months payback period, meaning the cost of acquiring a customer is recouped through revenue in less than four months. -Gross Margin: ~60% (up from 52% in Q2). This is a strong margin for a subscription supplement/health service, indicating healthy product pricing and cost control. -Subscription Rate: ~80% (Customers are sticking around). -Average Order Value (AOV): $150 (Up +36% from Q2). Higher initial spend helps fund the acquisition. -Customer Payback Period: 3.9 Months. This is remarkably fast. It means the cash spent to acquire a customer is recouped in less than four months from their subscription gross profit stream.

8/8 🧵The plan is simple and measurable: $180–200M FY-2026, and a path to $1B ARR by 2030 through focused product extensions and geographic expansion. TL;DR: repeatable product, improving economics, strong runway = real optionality to win.

7/8 🧵 We’re global by design: 420K+ customer purchases across 41 countries, with 56.5% of revenue outside the U.S. Add David Beckham as co-founder, Aryna Sabalenka’s authentic partnership and investment, a world-class scientific advisory board, and an unconventional Bitcoin treasury. Together, they change the rules of competition.

1/8 🧵 What if one product could rewrite the rules for building a global consumer brand? We launched a science-first supplement at $581K/mo and 11 months later it hit ~$9M/mo, the fastest growth in industry history. How did we do it? Read on.

Q3 results are in and here are the highlights: – We're growing at unprecedented speed. PRE revenue up 568% YoY to $23.6M - IM8: From $0 to $120M ARR in just 12 months - fastest supplement brand growth in industry history globally. – Clear path to scale. Projects $180-200M FY 2026 revenue, $25M monthly revenue and $300M ARR by end of 2026. – Global scale achieved rapidly. 420K+ customer purchases across 31 countries. 46.5% USA revenue and 56.5% international revenue demonstrates universal appeal of science-backed solutions. – Strong unit economics. 60% gross margins. 3.9-month customer payback period. 80% subscription rate. $150 AOV up 36% QoQ. Quality growth that compounds. – Strong balance sheet for aggressive scaling. $122M total liquidity ($82M cash + 387 BTC, valued at ~$40M Bitcoin). Zero debt. Financial strength to capture maximum market opportunity. – Dual-engine growth model. Health drives recurring revenue, wealth preserves value. Only NASDAQ consumer health company with Bitcoin treasury strategy, continuing 1 BTC purchase per day - Building toward 2030 $1B annual revenue vision with proven fundamentals and capital to execute. see my first shareholder letter here: prenetics.com/q3ceo full press release here: globenewswire.com/news-release/2…

JUST IN: $PRE Q325 Earnings 📈 Revenue +568% YoY to $23.6M 💪 IM8 hit $9M Oct. revenue, tracking $120M ARR by Dec - the fastest growing supplement brand ever 💰 36% MoM growth, ~80% subscription rates, $150 AOV, ~60% gross margin, payback 3.9 months - category leading unit economics 🏦 $120M liquidity, 387 BTC (~$41M) in treasury, zero debt 🎯 IM8 eyes $300M ARR by end-2026 Full Release: ir.prenetics.com/news-releases/…